ArticleScience translational medicine2025
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.
Yanyan Cai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it